Suppr超能文献

DNA-PKcs 的 PAR 化调节 DNA 损伤反应中的 DNA-PK 激酶活性。

DNA‑PKcs PARylation regulates DNA‑PK kinase activity in the DNA damage response.

机构信息

Institute for Environmental Medicine and Radiation Hygiene, School of Public Health, University of South China, Hengyang, Hunan 421001, P.R. China.

Department of Radiation Biology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.

出版信息

Mol Med Rep. 2019 Oct;20(4):3609-3616. doi: 10.3892/mmr.2019.10640. Epub 2019 Sep 2.

Abstract

DNA‑dependent protein kinase catalytic subunit (‑PKcs) is the core protein involved in the non‑homologous end‑joining repair of double‑strand breaks. In addition, it can form a complex with poly(ADP‑ribose) polymerase 1 (PARP1), which catalyzes protein PARylation. However, it is unclear how DNA‑PKcs interacts with PARP1 in the DNA damage response and how PARylation affects DNA‑PK kinase activity. Using immunoprecipitation, immunofluorescence and flow cytometry the present study found that DNA‑PKcs was PARylated after DNA damage, and the PARP1/2 inhibitor olaparib completely abolished DNA‑PKcs PARylation. Olaparib treatment prevented DNA‑PKcs protein detachment from chromatin after DNA damage and maintained DNA‑PK activation, as evidenced by DNA‑PKcs Ser2056 phosphorylation. Furthermore, olaparib treatment synergized with DNA‑PK inhibition to suppress cell survival. All of the above results are suggestive of the important role of DNA‑PKcs PARylation in regulating DNA‑PK activity.

摘要

DNA 依赖性蛋白激酶催化亚基(DNA-PKcs)是参与双链断裂非同源末端连接修复的核心蛋白。此外,它还可以与聚(ADP-核糖)聚合酶 1(PARP1)形成复合物,后者可催化蛋白 PAR 化。然而,DNA-PKcs 如何在 DNA 损伤反应中与 PARP1 相互作用以及 PAR 化如何影响 DNA-PK 激酶活性尚不清楚。本研究通过免疫沉淀、免疫荧光和流式细胞术发现,DNA-PKcs 在 DNA 损伤后发生 PAR 化,PARP1/2 抑制剂奥拉帕利完全消除了 DNA-PKcs 的 PAR 化。奥拉帕利处理可防止 DNA-PKcs 蛋白在 DNA 损伤后从染色质上脱离,并维持 DNA-PK 的激活,这可通过 DNA-PKcs Ser2056 磷酸化来证明。此外,奥拉帕利处理与 DNA-PK 抑制协同作用以抑制细胞存活。所有这些结果都提示 DNA-PKcs 的 PAR 化在调节 DNA-PK 活性方面起着重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6196/6755157/faae24d3845f/MMR-20-04-3609-g00.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验